FDA gives green light to America Stem Cell transplant trial

09/5/2013 | American City Business Journals

The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL
Technical Assistance Consultant (8336)
Am
Chicago, IL
Director of Professional Services
Engaging Schools, Inc.
Cambridge, MA
Principal at Timberland Charter Academy
Timberland Charter Academy
Muskegon, MI